ASH 2024 Summary: MPN Highlights and Clinical Implications

2024 ASH Annual Meeting Insights Hub

D. Tremblay

ASH 2024 Summary: Highlights in Bone Marrow Failure Disorders

2024 ASH Annual Meeting Insights Hub

P. Scheinberg

Thrombosis in Patients With ITP

Platelet Disorder Support Association (PDSA)

H. Liebman

Impact and Risks of Chronic Anemia in Thalassemia Patients

Farrukh Shah

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

Misinformation in ITP

Platelet Disorder Support Association (PDSA)

D. Nugent

ASH 2024 Review: New Therapies in ITP

Cleveland Clinic Taussig Cancer Institute

A. Hubben

How I Treat Anemia in Myelofibrosis

Cleveland Clinic Taussig Cancer Institute

A. Jain

Current Treatment Guidelines for ITP: Individualized Therapy and Eme…

Irina Murakhovskaya

2024 Updates on Myeloproliferative Neoplasms, PV, and ET

Integrity CE

A. Tefferi

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

Initial Approach and Considerations for Management of ITP

Nicoletta Machin

Is There a Role for Splenectomy in ITP?

Platelet Disorder Support Association (PDSA)

C. Kessler

Year in Review 2024 - Highlights in MPNs and Impact on Practice

Oncology 2024 Year in Review

P. Bose

Management of Treatment-Naive ITP Patients

Weill Cornell Medicine Oncology & Hematology

J. Bussel

Anemia and Thrombocytopenia Basics

UNC Lineberger Comprehensive Cancer Center

N. Vogler

Thrombocytopenia: Understanding Mechanisms and Inherited Forms

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

S. Panch

ASH 2024 Summary: Overview of Non-Surgical Management of Heavy Menst…

2024 ASH Annual Meeting Insights Hub

A. Wheeler